STATUTORY RULES
1966 No. 80
_________
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1965.*
I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1965.
Dated this twenty-first day of April, 1966.
CASEY
Governor-General.
By His Excellency’s Command,
(Signed) A. G. Forbes
Minister of State for Health.
_______
Amendments of the National Health (Pharmaceutical Benefits) Regulations†
Commencement.
1. These Regulations shall come into operation on the first day of May, 1966.
First, Second, Third, Fourth and Fifth Schedules.
2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—
FIRST SCHEDULE
Regulation 10.
Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as, or except as specially provided used in, pharmaceutical Benefits.
Acetomenaphthone. | Apomorphine Injection. |
Acetomenaphthone Tablets. | Bacillus Calmette-Guérin Vaccine. |
Acetrizoic Acid. | Bemegride. |
Alcohol (95%). | Benzhexol Hydrochloride. |
Dilute Alcohols. | Benztropine Methanesulphonate. |
Dehydrated Alcohol. | Betamethasone. |
Almond Oil. | Bisacodyl. |
Amethocaine Hydrochloride. | Bisacodyl Suppositories. |
Amodiaquine Hydrochloride. | Bisacodyl Tablets. |
Amphetamine Sulphate. | Botulinum Antitoxin. |
Amylobarbitone Sodium Tablets. | Busulphan. |
Antazoline Hydrochloride. | Butobarbitone. |
Antimony Potassium Tartrate. | Butylated Hydroxyanisole. |
Antimony Potassium Tartrate Injection. | Butylated Hydroxytoluene. |
Antimony Sodium Tartrate. | Calciferol Solution. |
Antimony Sodium Tartrate Injection. | Calcium Cyclamate. |
Apomorphine Hydrochloride. | Caramiphen Hydrochloride. |
* Notified in the Commonwealth Gazette on 28 April, 1966.
† Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1964, Nos. 12, 57 and 135; and 1965, Nos. 51, 151 and 152.
3989/66.—Price 25c (2s. 6d.) 9/14.4.1966
First Schedule—continued
Caramiphen Tablets. | Dimethisterone Tablets. |
Caraway. | Diodone Injection. |
Carbimazole. | Diphtheria and Pertussis Vaccine. |
Carbon Dioxide. | Dipipanone Hydrochloride. |
Carbromal Tablets. | Dipipanone Injection. |
Cardamom Fruit. | Dodecyl Gallate. |
Cascara. | Domiphen Bromide. |
Catgut, Sterilised Surgical. | Edrophonium Chloride. |
Cellulose, Oxidised. | Emetine and Bismuth Iodide. |
Cetylpyridinium Chloride. | Emetine Hydrochloride. |
Chloral Betaine. | Erythromycin. |
Chlorambucil. | Ethinyloestradiol. |
Chloroquine Phosphate. | Ethisterone. |
Chloroquine Sulphate. | Ethopropazine Hydrochloride. |
Chlorothiazide. | Ethotoin. |
Chlorphenesin. | Ethyl Chloride. |
Chlorpropamide. | Ethyl Oleate. |
Chorionic Gonadotrophin. | Ethylenediamine Hydrate. |
Chorionic Gonadotrophin Injection. | Eugenol. |
Cinchocaine Hydrochloride. | Ferric Citrate (30Fe) Injection. |
Cinnamon. | Fludrocortisone Acetate. |
Citric Acid, Anhydrous. | Fluocinolone Acetonide. |
Cochineal. | Fluoxymesterone. |
Colchicine. | Gallamine Triethiodide. |
Colchicum Corm. | Gallamine Injection. |
Colchicum Liquid Extract. | Gelatin Sponge, Absorbable. |
Coriander. | Gentian. |
Corticotrophin. | Ginger. |
Cresol and Soap Solution. | Glutethimide. |
Cresol. | Gold (108Au) Injection. |
Crotamiton. | Griseofulvin. |
Cyanocobalamin. | Guanethidine Sulphate. |
Cyanocobalamin (57Co). | Halothane. |
Cyanocobalamin (58Co). | Helium. |
Cyclamic Acid. | Heparin. |
Cyclizine Tablets. | Hexamethonium Tartrate. |
Cyclobarbitone Calcium. | Hexamethonium Tartrate Injection. |
Cyclomethycaine Sulphate. | Hexylresorcinol. |
Cyclopropane. | Histamine Acid Phosphate. |
Dapsone. | Human Blood, Whole. |
Deoxycortone Trimethylacetate. | Human Red Blood Corpuscles, Concentrated. |
Dequalinium Acetate. | Human Fibrin Foam. |
Dequalinium Chloride. | Human Fibrinogen. |
Dexamethasone. | Human Gamma Globulin. |
Dexamethasone Acetate. | Human Gamma Globulin Injection. |
Dexamphetamine Sulphate. | Human Plasma, Dried. |
Dextromethorphan Hydrobromide. | Human Serum, Dried. |
Dextromethorphan Tablets. | Human Thrombin. |
Diamorphine Hydrochloride. | Hydrallazine Hydrochloride. |
Diamorphine Injection. | Hydrallazine Tablets. |
Dibromopropamidine Isethionate. | Hydrocortisone Ointment. |
Dichloralphenazone. | Hydrocortisone Acetate Ointment. |
Dichloralphenazone Tablets. | Hydrocortisone Hydrogen Succinate. |
Dichlorophen. | Hydroflumethiazide. |
Dichlorphenamide. | Hydrogen Peroxide Solution, Strong. |
Diethazine Hydrochloride. | Hydroxocobalamin. |
Diethylcarbamazine Citrate. | Hydroxychloroquine Sulphate. |
Digitoxin. | Hyoscyamus. |
Diloxanide Furoate. | Imipramine Hydrochloride. |
Dimenhydrinate. | Indigo Carmine. |
Dimenhydrinate Injection. | Influenza Vaccine. |
Dimenhydrinate Tablets. | Iodinated (131I) Human Serum Albumin Injection. |
Dimercaprol. | Iodipamide Methylglucamine Injection. |
Dimethisterone. | Iodised Oil Fluid Injection. |
First Schedule—continued
Iodised Oil Viscous Injection. | Opium, Powdered. |
Iopanoic Acid. | Orange Peel, Dried Bitter. |
Iopanoic Acid Tablets. | Orange Peel, Fresh Bitter. |
Iophendylate Injection. | Oxygen. |
Ipecacuanha, Prepared. | Oxytetracycline Dihydrate. |
Ipecacuanha and Opium Tablets. | Paramethadione. |
Isoniazid. | Pempidine Tartrate. |
Isopropyl Alcohol. | Pentamidine Isethionate. |
Lead Acetate. | Pentamidine Injection. |
Lead Monoxide. | Perphenazine. |
Lemon Peel, Dried. | Perphenazine Tablets. |
Levallorphan Injection. | Pethidine Tablets. |
Levorphanol Tartrate. | Phanquone. |
Lignocaine Hydrochloride. | Phanquone Tablets. |
Lignocaine and Adrenaline Injection. | Phenelzine Sulphate. |
Lignocaine Hydrochloride Injection. | Phenelzine Tablets. |
Liothyronine Sodium. | Phenindamine Tartrate. |
Lucanthone Hydrochloride. | Phenindione. |
Lucanthone Tablets. | Phenolphthalein Tablets. |
Magnesium Stearate. | Phenolsulphonphthalein. |
Male Fern. | Phenoxybenzamine Hydrochloride. |
Maleic Acid. | Phenoxymethylpenicillin. |
Mannitol. | Phentolamine Hydrochloride. |
Measles Vaccine (Inactivated). | Phentolamine Tablets. |
Measles Vaccine (Live Attenuated). | Phentolamine Methanesulphonate. |
Mecamylamine Hydrochloride. | Phentolamine Injection. |
Melarsoprol. | Phytomenadione. |
Menaphthono Sodium Bisulphite. | Phytomenadione Capsules. |
Mepacrine Hydrochloride. | Phytomenadione Tablets. |
Mephentermine Sulphate. | Picrotoxin. |
Mephentermine Tablets. | Piperazine Citrate. |
Meprobamate. | Piperocaine Hydrochloride. |
Meprobamate Tablets. | Poldine Methylsulphate. |
Mercaptopurine. | Poldine Tablets. |
Mersalyl Acid. | Poliomyelitis Vaccine (Inactivated). |
Methadone Hydrochloride. | Poliomyelitis Vaccine (Oral). |
Methandienone. | Potassium Chloride Injection. |
Methoin. | Potassium Perchlorate. |
Methyl Hydroxybenzoate. | Prednisone. |
Methylamphetamine Hydrochloride. | Prednisone Acetate. |
Methyldopa. | Primaquine Phosphate. |
Methylthiouracil. | Primidone. |
Methylthiouracil Tablets. | Probenecid. |
Methyprylone. | Procainamide Hydrochloride. |
Methyprylone Tablets. | Procaine and Adrenaline Injection. |
Metronidazole. | Prochlorperazine Maleate. |
Nalorphine Hydrobromide. | Prochlorperazine Methanesulphonate. |
Nandrolone Phenylpropionate. | Prochlorperazine Tablets. |
Naphazoline Hydrochloride. | Procyclidine Hydrochloride. |
Neostigmine Bromide. | Progesterone. |
Nicotinic Acid. | Proguanil Hydrochloride. |
Nikethamide. | Promazine Hydrochloride. |
Nikethamide Injection. | Promazine Injection. |
Nitrous Oxide. | Promazine Tablets. |
Norethandrolone. | Promethazine Theoclate. |
Norethandrolone Tablets. | Promethazine Theoclate Tablets. |
Norethisterone. | Propyl Gallate. |
Norethisterone Tablets. | Propyl Hydroxybenzoate. |
Noscapine. | Propyliodone. |
Novobiocin Calcium. | Propyliodone Injection. |
Novobiocin Sodium. | Propyliodone Oily Injection. |
Nux Vomica. | Propylthiouracil. |
Octyl Gallate. | Pyridostigmine Bromide. |
Oestradiol Benzoate. | Pyrimethamine. |
Opium. | Quillaia. |
First Schedule—continued
Rabies Antiserum. | Suramin Injection. |
Rabies Vaccine. | Suxamethonium Chloride. |
Senna Leaf. | Testosterone. |
Sesame Oil. | Testosterone Phenylpropionate. |
Soda Lime. | Testosterone Phenylpropionate Injection. |
Sodium Acetrizoate Injection. | Testosterone Propionate. |
Sodium Anoxynaphthonate. | Tetrachloroethylene. |
Sodium Antimonylgluconate. | Tetrachloroethylene Capsules. |
Sodium Antimonylgluconate Injection. | Thiambutosine. |
Sodium Aurothiomalate. | Thiomersal. |
Sodium Bicarbonate Compound Tablets. | Thiopentone Sodium. |
Sodium Bicarbonate Injection. | Thiopentone Injection. |
Sodium Calciumedetate. | Thioridazine Hydrochloride. |
Sodium Chromate (51Cr) Solution. | Thyroid. |
Sodium Cyclamate. | Thyroxine Sodium. |
Sodium Diatrizoate. | Tolazoline Hydrochloride. |
Sodium Diatrizoate Injection. | Tolbutamide. |
Sodium Fluoride. | Trichloroethylene. |
Sodium Fusidate Capsules. | Triclofos Sodium. |
Sodium Iodide (181I) Injection. | Triclofos Tablets. |
Sodium Iodide (101I) Solution. | Trifluoperazine Hydrochloride. |
Sodium Lauryl Sulphate. | Tripelennamine Hydrochloride. |
Sodium Phosphate (88P) Injection. | Tryparsamide. |
Sodium Stibogluconate. | Tryparsamide Injection. |
Sodium Stibogluconate Injection. | Tuberculin, Old. |
Solapsone. | Tuberculin Purified Protein Derivative. |
Solapsone Tablets. | Tubocurarine Chloride. |
Spironolactone. | Tubocurarine Injection. |
Staphylococcus Antitoxin. | Typhoid-Paratyphoid A and B and Cholera Vaccine. |
Stibophen. | Typhoid-Paratyphoid A and B and Tetanus Vaccine. |
Stibophen Injection. | Typhoid-Paratyphoid A, B, and C Vaccine |
Stramonium. | Undecenoic Acid. |
Sulphadimidine Sodium. | Vancomycin Hydrochloride. |
Sulphamethizole. | Vancomycin Injection. |
Sulphamethoxypyridazine. | Vinyl Ether. |
Sulphapyridine. | Vitamin A Ester Concentrate. |
Sulphasomidine. | Yellow Fever Vaccine. |
Sulphasomidine Tablets. | Zinc Undecenoate. |
Sulphobromophthalein Sodium. | Zinc Undecenoate Ointment. |
Suramin |
|
__________
SECOND SCHEDULE
Regulation 10 (3.).
Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations
Pharmaceutical Benefits | Allowable Compounds (if any) |
Acrylic Resin ............................ | __ |
Aluminium Powder, B.P.C. .................. | Aluminium Powder B.P.C. with Liquid Paraffin B.P. and Zinc Oxide Ointment B.P. |
Aluminium Sodium Silicate................... | Aluminium Sodium Silicate with Belladonna |
Amphotericin B. .......................... | Tetracycline with a buffering agent and Amphotericin B. |
Aneurine Hydrochloride, B.P. ................. | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Antazoline Sulphate........................ | Antazoline Sulphate with Naphazoline Nitrate B.P. |
Second Schedule—continued
Pharmaceutical Benefits | Allowable Compounds (if any) |
Ascorbic Acid, B.P............................. | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Attapulgite.................................. | Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P. |
| |
Bacitracin, B.P............................... | Polymyxin B Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P. |
Betamethasone Disodium Phosphate | — |
Betamethasone Phosphate........................ | — |
Calciferol.................................. | — |
Calcium Lactobionate.......................... | Thenalidine with Calcium Lactobionate |
Carbachol, B.P............................... | — |
Carbinoxamine Maleate......................... | — |
Carbromal, B.P............................... | Carbromal B.P., with Pentobarbitone Sodium B.P. |
Chloramine, B.P.............................. | — |
Chloramphenicol, B.P........................... | Chloramphenicol B.P. with Polymyxin B. Sulphate B.P. |
Chlorhexidine Gluconate ........................ | — |
Chlorpheniramine Maleate, B.P.................... | — |
Chlorpromazine Hydrochloride, B.P. | — |
Chlortetracycline Hydrochloride, B.P. | — |
Clemizole Tannate............................ | — |
Cortisone Acetate, B.P.......................... | — |
Cymogran.................................. | — |
Cyproheptadine Hydrochloride.................... | — |
Cyclizine Hydrochloride, B.P..................... | Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P. |
Demecarium Bromide.......................... | — |
Demethylchlortetracycline Hydrochloride, B.P........... | — |
Dexchlorpheniramine Maleate..................... | — |
Dextran.................................... | Dextran with Dextrose B.P. |
| Dextran in Normal Saline |
Dicyclomine Hydrochloride, B.P.C.................. | — |
Dienoestrol, B.P............................... | — |
Digoxin, B.P................................. | — |
Dihydrostreptomycin Sulphate, B.P. 1958 | Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P. |
| Dihydrostreptomycin Sulphate B.P. 1958 with Kaolin, Pectin and Aluminium Hydroxide Gel |
Dihydrotachysterol............................ | — |
Dimethicone ................................ | — |
Diphenhydramine Hydrochloride, B.P................ | Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P. |
Diphenylpyraline Hydrochloride................... | — |
Diphtheria Vaccine, B.P......................... | Diphtheria and Tetanus Vaccine B.P. |
| Diphtheria, Tetanus and Pertussis Vaccine B.P. |
Dyflos, B.P.C................................ | — |
Ecothiopate Iodide............................ | — |
Entsufon................................... | Hexachlorophane B.P. with Entsufon |
Ergometrine Maleate........................... | Oxytocin with Ergometrine Maleate |
Ergotamine Tartrate, B.P......................... | Ergotamine Tartrate B.P. with Caffeine B.P. |
| Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P. |
| Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P. |
| Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P. |
Erythromycin Oral Suspensions and Syrups | — |
Second Schedule—continued
Pharmaceutical Benefits | Allowable Compounds (if any) |
Erythromycin Paediatric Drops.................. | — |
Ethosuximide ............................. | — |
Ferric Hydroxide ........................... | — |
Ferrous Aminoacetosulphate ................... | — |
Ferrous Succinate........................... | — |
Framycetin Sulphate......................... | — |
Fusidic Acid (Diethanolamine Salt)............... | — |
Galactomin............................... | — |
Glucose Indicator........................... | — |
Gramicidin............................... | Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin |
Hamamelis Dry Extract, B.P.C.................. | Hamamelis Dry Extract B.P.C. with Zinc Oxide, B.P. |
Hexachlorophane, B.P........................ | Hexachlorophane B.P. with Entsufon |
| Hexachlorophane B.P. with Lissapol |
| Hexachlorophane B.P. in Soap Solution |
Hydrocortisone, B.P......................... | — |
Hydrocortisone Acetate, B.P.................... | Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P. |
Ipecacuanha, B.P........................... | Phenolphthalein B.P. with Aloin B.P.C., Dry Extract of Belladonna B.P., Strychnine B.P.C. 1959 and Ipecacuanha B.P. |
Isoprenaline Hydrochloride.................... | — |
Kanamycin Sulphate, B.P.C.................... | — |
Levallorphan Tartrate, B.P..................... | Levallorphan Tartrate B.P. with Pethidine Hydrochloride B.P. |
Lissapol................................. | Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P. |
| Hexachlorophane B.P. with Lissapol |
Lofenalac................................ | — |
Magnesium Chloride......................... | Ammonium Chloride B.P. with Sodium Chloride B.P., Potassium Chloride B.P. and Magnesium Chloride |
| Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P. |
Mebhydrolin Napadisylate, B.P.C................. | — |
Meclozine Hydrochloride, B.P................... | Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P. |
Mepyramine Maleate, B.P...................... | — |
Methacycline.............................. | — |
Methdilazine Hydrochloride.................... | — |
Methyl Glucamine.......................... | Theophylline B.P. with Methyl Glucamine |
Minafen ................................. | — |
Morphine Tartrate........................... | Morphine Tartrate with Tacrine |
Naphazoline Nitrate, B.P....................... | Naphazoline Nitrate B.P. with Antazoline Sulphate |
Neomycin Sulphate, B.P....................... | Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P. |
| Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P. |
| Neomycin Sulphate B.P. with Kaolin B.P. |
| Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin |
Neostigmine Methylsulphate, B.P................. | — |
Nicotinamide, B.P........................... | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Nitrofurantoin, B.P.......................... | — |
Nortriptyline Hydrochloride.................... | — |
Nystatin, B.P.............................. | Tetracycline with a buffering agent and Nystatin B.P. |
| Oxytetracycline Hydrochloride B.P. with a buffering agent and Nystatin B.P. |
Oxytetracycline Hydrochloride, B.P............... | Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P. |
| Oxytetracycline Hydrochloride B.P. with a buffering agent and Nystatin B.P. |
Second Schedule—continued
Pharmaceutical Benefits | Allowable Compounds (if any) |
Oxytocin ................................ | Oxytocin with Ergometrine Maleate |
Pancreatin Enzyme, U.S.N.F. XI................. | — |
Papaveretum, B.P.C.......................... | Papaveretum B.P.C. with Hyoscine Hydrobromide B.P. |
Penicillin, Benethamine, B.P.C................... | Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P. |
Penicillin, Benzathine, B.P..................... | Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P. |
Penicillin, Benzyl, B.P........................ | Penicillin, Benzyl B.P. with Streptomycin Sulphate B.P. |
| Fortified Procaine Penicillin Injection B.P. |
| Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P. |
Penicillin, Phenoxymethyl (Benzathine, Calcium, Hydrabamine or Potassium Salt or Free Acid) | — |
Penicillin, Potassium, B.P...................... | Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P. |
Penicillin, Procaine, B.P....................... | Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P. |
| Fortified Procaine Penicillin Injection B.P. |
| Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P. |
| Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P. |
Penicillin, Sodium, B.P........................ | Penicillin, Benethamine B.P. with Procaine Penicillin B.P. and Sodium Penicillin B.P. |
Pentolinium Tartrate, B.P...................... | Pentolinium Tartrate B.P. with Ephedrine Hydrochloride B.P. |
Pertussis Vaccine, B.P........................ | Diphtheria, Tetanus and Pertussis Vaccine B.P. |
Pethidine Hydrochloride, B.P.................... | Pethidine Hydrochloride B.P. with Levallorphan Tartrate B.P. |
| Pethidine Hydrochloride B.P. with Scopolamine Hydrobromide B.P. |
Phenethicillin Potassium...................... | — |
Pheniramine Maleate......................... | — |
Phenytoin................................ | — |
Pipenzolate Methobromide..................... | — |
Pituitary (Posterior Lobe), Powdered, B.P.C.......... | — |
Polymyxin B. Sulphate, B.P..................... | Chloramphenicol B.P. with Polymyxin B. Sulphate B.P. |
| Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P. |
| Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P. |
| Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin |
| Polymyxin B. Sulphate B.P. with Propylene Glycol and Acetic acid |
Methylprednisolone, B.P....................... | — |
Prednisolone Sodium Hemisulphate............... | — |
Prednisolone Sodium Phosphate, B.P.C. | — |
Prednisolone Trimethylacetate, B.P................ | — |
Promethazine Hydrochloride, B.P................. | — |
Riboflavine, B.P............................ | Vitamin A with Aneurine Hydrochloride B.P. Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Senna Fruit, B.P............................ | — |
Second Schedule—continued
Pharmaceutical Benefits | Allowable Compounds (if any) |
Silver Nitrate, Toughened, B.P..................... | — |
Sobee..................................... | — |
Sodium Lactate............................... | Sodium Lactate with Potassium Chloride B.P. and Sodium Chloride B.P. |
| Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P. |
| Sodium Lactate with Sodium Chloride B.P. and Dextrose B.P. |
| Sodium Lactate with Sodium Chloride B.P. |
| Sodium Lactate with Potassium Chloride B.P. and Dextrose B.P. |
Sodium Potassium Tartrate, B.P.C. | Compound Effervescent Powder, B.P.C. |
Sodium Tauroglycocholate, B.P.C. 1954 | Sodium Tauroglycocholate B.P.C. 1954 with Cascara Dry Extract B.P. |
Spearmint Oil, B.P.C........................... | Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P. |
Strychnine, B.P.C. 1959......................... | Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine B.P.C. 1959 and Ipecacuanha |
Sulphacetamide, B.P.C.......................... | Sulphacetamide B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P. |
Sulphafurazole, B.P............................. | — |
Sulphamerazine, B.P. 1958....................... | Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphathiazole B.P.C. |
| Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphacetamide B.P.C. |
| Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphadimidine B.P. |
Sulphaphenazole, B.P.C......................... | — |
Sulphathiazole, B.P.C........................... | Sulphathiazole B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P. |
Surgical Cement ............................. | — |
Surgical Cement Solvent........................ | — |
Tacrine.................................... | Morphine Sulphate B.P. with Tacrine |
| Morphine Tartrate with Tacrine |
Tetanus Vaccine, B.P........................... | Diphtheria and Tetanus Vaccine B.P. |
| Diphtheria, Tetanus and Pertussis Vaccine B.P. |
Tetracycline Hydrochloride, B.P.................... | Tetracycline Hydrochloride B.P. with a buffering agent |
Tetracycline................................. | Tetracycline with a buffering agent and Amphotericin B. |
| Tetracycline with a buffering agent and Nystatin B.P. |
Thenalidine................................. | Thenalidine with Calcium Lactobionate |
Thenalidine Tartrate........................... | Thenalidine Tartrate with Calcium Lactate B.P. and Calcium Gluconate B.P. |
Theobromine, B.P.C............................ | Theobromine B.P.C. with Phenobarbitone B.P. |
Thioridazine................................. | — |
Tragacanth (Gum Karaya)....................... | — |
Trimeprazine Tartrate, B.P.C...................... | — |
Triprolidine Hydrochloride, B.P.C................... | — |
Vasopressin................................. | — |
Velactin................................... | — |
Viomycin Pantothenate......................... | Viomycin Sulphate B.P. with Viomycin Pantothenate |
Viomycin Sulphate, B.P......................... | Viomycin Sulphate B.P. with Viomycin Pantothenate |
Viprynium Embonate........................... | — |
Vitamin A.................................. | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Vitamin D.................................. | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
THIRD SCHEDULE
Regulation 11.
Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia
Acetazolamide Sodium. | Calamine Cream Oily, A.P.F. |
Acetohexamide. | Calcium Aurothiomalate. |
Acidified Golden Syrup, A.P.F. 1955. | Calcium Di-Oxytetracycline. |
Acriflavine, B.P.C. | Calcium Gluconogalactogluconate. |
Acrylic Resin. | Calcium Lactobionate. |
Adrenaline Hydrochloride. | Calcium Phosphate, B.P.C. |
Adrenaline Mucate. | Calumba, Concentrated Infusion, B.P. 1948. |
Agar, B.P.C. 1954. | Calumba Tincture, B.P. 1948. |
Alkavervir. | Capsicum Ointment, B.P.C. |
Aloin, B.P.C. | Capsicum Tincture, B.P.C. |
Almond Oil Volatile Bitter, B.P.C. 1959. | Carbamazepine. |
Aloxidone. | Carbarsone, B.P.C. |
Aluminium Acetate Solution, B.P.C. | Carbinoxamine Maleate. |
Aluminium Hydroxide Mixture, A.P.F. | Cardamom Aromatic Tincture, B.P.C. |
Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex. | Catechu Tincture, B.P.C. |
Cephaloridine. | |
Aluminium Sodium Silicate. | Cetomacrogol Emulsifying Wax, B.P.C. |
Aluminium Powder, B.P.C. | Cetyl Alcohol Compound. |
Amaranth Solution, A.P.F. | Chloramine, B.P.C. |
Amaranth Solution, Compound, A.P.F. | Chloramphenicol Palmitate, B.P.C. |
Amaranth Solution, B.P.C. | Chloramphenicol Stearate. |
Aminocaproic Acid. | Chloramphenicol Succinate. |
Amitriptyline Hydrochloride. | Chlorazanil Hydrochloride. |
Ammonia Aromatic Spirit, B.P.C. | Chlorhexidine Diacelate. |
Ammonia Solution Strong, B.P.C. | Chlorhexidine Gluconate. |
Ammonium Bicarbonate, B.P.C. | Chlorobenzol Disulphonamide. |
Ammonium Bromide, B.P.C. | Chlorotrianisene, B.P.C. |
Amphotericin B. | Chlorthalidone, B.P.C. |
Angiotensin Amide. | Cholera El Tor Combined Vaccine. |
Antazoline Methanesulphonate, B.P.C. | Choline Theophyllinate, B.P.C. |
Antazoline Sulphate. | Cinnamon Spirit, B.P.C. 1949. |
Attapulgite. | Cinnamon Water, Concentrated, B.P.C. |
Aurothioglucose. | Clemizole Hydrochloride. |
Azathioprine. | Clemizole Tannate. |
Beclamide. | Cloipamide. |
Beeswax, Yellow, B.P.C. | Clove, Concentrated Infusion, B.P.C. 1954. |
Belladonna Suppository, B.P. 1948. | Coal Tar, B.P.C. |
Benedict’s Solution, A.P.F. | Cochineal Tincture, B.P. 1948. |
Benzalkonium Chloride. | Coconut Oil, B.P.C. 1949. |
Benzoin, B.P.C. | Codeine, B.P.C. 1954. |
Benzoinated Lard, B.P.C. 1954. | Copper Sulphate, B.P.C. |
Benzoin Compound Tincture, B.P.C. | Creosote, B.P.C. 1959. |
Benzoin Tincture, B.P.C. | Cudbear Tincture, A.P.F. 1947. |
Benzylpenicillin in Oil. | Curd Soap, B.P.C. |
Bephenium Hydroxynaphthoate, B.P.C. | Cyclopenthiazide. |
Betamethasone Disodium Phosphate. | Cyclothiazide. |
Betamethasone Phosphate. | Cycrimine Hydrochloride. |
Bethanidine Sulphate. | Cymogran. |
Biperiden Hydrochloride. | Cyproheptadine Hydrochloride. |
Bismuth Subgallate, B.P.C. | Death Adder Antivenene. |
Bretylium Tosylate. | Demecarium Bromide. |
Brompheniramine. | Deoxycortone Glucoside. |
Brown Snake Antivenene. | Desferrioxamine. |
Buchu Concentrated Infusion, B.P.C. 1954. | Deslanoside. |
Butabarbital Sodium. | Dexamethasone Sodium Phosphate. |
Butyl Aminobenzoate, B.P. 1953 | Dexchlorpheniramine Maleate. |
Cade Oil, B.P.C. | Dextran. |
Caffeine and Sodium Benzoate, B.P.C. 1954. | Dextriferron. |
Caffeine Citrate, B.P.C. 1959. | Dicyclomine Hydrochloride, B.P.C. |
Cajuput Spirit, B.P. 1948. | Digitalis Tincture, B.P.C. 1959 |
Third Schedule—continued
Dihydroergotamine Methanesulphonate. | Hyoscine Methobromide. |
Dihydromorphinone Hydrochloride, B.P.C. 1949. | Hypophosphorous Acid, Dilute, B.P.C. |
Dihydrostreptomycin Sulphate, B.P. 1958. | Idoxuridine. |
Dihydrotachysterol. | Indomethacin. |
Dimethicone, B.P.C. | Insulin Injection, specially purified. |
Dimethindene Maleate. | Insulin Isophane Injection, specially purified. |
Diphenylpyraline Hydrochloride. | Insulin Injection, Special P (Pig). |
Dipyridamole. | Iodochlorhydroxyquinoline. |
Disodium Stilboestrol Diphosphate. | Iodoform, B.P.C. 1954. |
Dithiazanine Iodide. | Iron Aminoates. |
Dyflos, B.P.C. | Iron Dextran. |
Ecothiopate Iodide. | Iron Oxide Saccharated. |
Entsufon. | Iron Sorbitol Complex. |
Ephedrine, B.P.C. | Isoprenaline Hydrochloride. |
Ergot, Liquid Extract, B.P. 1914. | Isopropamide Iodide. |
Erythromycin Ethyl Succinate. | Isothipendyl Hydrochloride, B.P.C. |
Erythromycin Glucoheptonate. | Kanamycin Sulphate, B.P.C. |
Erythromycin Lactobionate. | Kitasamycin. |
Erythromycin Stearate. | Lanatoside-C. |
Ethacrynic Acid. | Lavender Spike Oil, B.P.C. |
Ethanolamine, B.P.C. | Lemon Tincture, B.P. 1958. |
Ethanolamine Oleate. | Lincomycin Hydrochloride. |
Ether Nitrous Spirit, B.P.C. 1959. | Lipopancreatin. |
Ethionamide. | Lissapol. |
Ethoxzolamide. | Lobelia Ethereal Tincture, B.P.C. |
Ethylidene Dicoumarin. | Lofenalac. |
Ethylnoradrenaline Hydrochloride. | Lypressin. |
Ethyloestrenol. | Magenta, B.P.C. |
Eucalyptol, B.P.C. | Magnesium Chloride. |
Extract of Ox Bile, B.P. 1948. | Magnesium Hydroxide, B.P.C. |
Ferric Hydroxide. | Mebhydrolin Napadisylate, B.P.C. |
Ferrous Aminoacetosulphate. | Medroxyprogesterone Acetate. |
Ferrous Carbonate Saccharated, B.P.C. 1959. | Melphalan. |
Ferrous Phosphate Compound Syrup, B.P.C. | Mepenzolate Bromide. |
Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C. | Mercaptomerin Sodium. |
Ferrous Succinate. | Mercuric Chloride, B.P.C. |
Fluorouracil Sodium. | Mestanolone. |
Folinic Acid. | Metaraminol Bitartrate. |
Framycetin Sulphate. | Metformin Hydrochloride. |
Frusemide. | Methacycline. |
Fusidic Acid, Diethanolamine Salt. | Methazolamide. |
Galactomin. | Methdilazine Hydrochloride. |
Gall and Opium Ointment, B.P.C. | Methenamine Mandelale. |
Gelsemium Tincture, B.P.C. | Methenolone Acetate. |
Glucagon Hydrochloride. | Methotrexate. |
Glucose Indicator. | Methoxamine Hydrochloride, B.P.C. |
Glycerophosphate Compound Syrup, A.P.F. | Methsuximide. |
Glycopyrronium Bromide. | Methyclothiazide. |
Goats Milk, dehydrated. | Methyl Glucamine. |
Gramicidin. | Methylphenobarbitone, B.P.C. |
Hamamelis Dry Extract, B.P.C. | Methylprednisolone Acetate. |
Hamamelis Liquid Extract, B.P.C. | Metyrapone. |
Heparin Retard. | Minafen. |
Hexocyclium Methylsulphate. | Morphine Tartrate. |
Honey, Purified, B.P.C. | Myrrh Gum, Powdered, B.P.C. |
Hydrargaphen. | Myrrh Tincture, B.P.C. |
Hydrocyanic Acid, Dilute, B.P.C. 1954. | Nalidixic Acid. |
Hydroxybenzoate Compound Powder, A.P.F. | Nandrolone Decanoate. |
Hydroxyprogesterone Caproate. | Natamycin. |
| Niclosamide. |
| Nicotinyl Alcohol Tartrate. |
| Nicoumalone. |
| Nitromin. |
| Nortriptyline Hydrochloride. |
|
|
Third Schedule—continued
Nux Vomica, Dry Extract, B.P.C. | Quillaia Tincture, B.P.C. |
Oestradiol Dipropionate, B.P.C. 1954. | Quinethazone. |
Oestrone, B.P.C. 1954. | Raspberry Syrup, B.P.C. |
Oily Ophthalmic Vehicle, A.P.F. 1955. | Rauwolfia Alkaloids. |
Orange Peel Compound, Concentrated Infusion, B.P.C. 1954. | Red Back Spider Antivenene. |
Orange Peel, Concentrated Infusion, B.P.C. | Rolitetracycline. |
Orciprenaline Sulphate. | Rosemary Oil, B.P.C. |
Oxycodone Pectinate. | Salicylamide. |
Oxymel, B.P.C. | Senega, Concentrated Infusion, B.P.C. |
Oxymel of Squill, B.P.C. | Senna Compound Mixture, B.P.C. 1959. |
Oxymesterone. | Senna, Concentrated Infusion, B.P.C. 1959. |
Oxyphencyclimine Hydrochloride. | Senna Fruit Extract (Standardised). |
Oxyphenonium Bromide. | Siberian Fir Oil, B.P.C. 1949. |
Oxytetracycline. | Silver Protein, B.P.C. |
Oxytocin. | Silver Protein Mild, B.P.C. |
Pancreatin Enzyme, U.S.N.F. XI. | Sobee. |
Papaveretum, B.P.C. | Sodium Carbonate Anhydrous, B.P.C. |
Para-Aminosalicylic Acid. | Sodium Edetate, B.P.C. |
Paraben Ophthalmic Phosphate Buffer, A.P.F. 1955. | Sodium Folate. |
Paraben Ophthalmic Vehicle, A.P.F. 1955. | Sodium Lactate. |
Paraffin Liquid Light, B.P.C. | Sodium Nitrite, B.P.C. |
Paramethasone Acetate. | Sodium Potassium Tartrate, B.P.C. |
Pargyline Hydrochloride. | Sodium Tauroglycocholate, B.P.C., 1954. |
Pectin. | Spearmint Oil, B.P.C. |
d-Penicillamine Hydrochloride, B.P.C. | Spiramycin. |
Penicillinase. | Squill Tincture, B.P.C. |
Penicillin, Benethamine, B.P.C. | Stanolone. |
Pentaerythritol Tetranitrate, diluted, B.P.C. | Stanozolol. |
Penthienate Methobromide. | Stearic Acid, B.P.C. |
Pertussis Vaccine (Haemagglutinin Aluminium Phosphate Adsorbed). | Storax, Prepared, B.P.C. |
Peru Balsam, B.P.C. | Strophanthus Tincture, B.P. 1948. |
Phenazone, B.P.C. | Strychnine, B.P.C. 1959. |
Phenazopyridine Hydrochloride. | Sulphacetamide, B.P.C. |
Phenethicillin Potassium. | Sulphadiazine Sodium, B.P.C. |
Phenformin Hydrochloride. | Sulphadimethoxine, B.P.C. |
Pheniramine Maleate. | Sulphaguanidine, B.P.C. |
Pheniramine Para-Aminosalicylate. | Sulphamerazine, B.P. 1958. |
Phenol Ointment, B.P. 1948. | Sulphamethoxydiazine. |
Phenoxymethylpenicillin, Benzathine. | Sulphaphenazole, B.P.C. |
Phenoxymethylpenicillin, Hydrabamine. | Sulphasalazine. |
Phensuximide. | Sulphathiazole, B.P.C. |
Phenthimentonium. | Sulphinpyrazone, B.P.C. |
Phenytoin. | Sulphomyxin Sodium. |
Phthalylsulphacetamide. | Sulphurated Potash, B.P.C. |
Physostigmine, B.P.C. | Sulphuric Acid, Dilute, B.P.C. |
Pipenzolate Methobromide. | Sulphur Sublimed, B.P.C. |
Pituitary (Posterior Lobe) Powdered, B.P.C. | Sultiame. |
Polythiazide. | Surgical Cement. |
Potable Water. | Surgical Cement Solvent. |
Potassium Chlorate, B.P.C. | Sustanon. |
Potassium, Effervescent Tablets. | Syrup Glucose Liquid, B.P.C. |
Prednisolone Sodium Hemisuccinate. | Tacrine. |
Prednisolone Sodium Hemisulphate. | Taipan Antivenene. |
Prednisolone Sodium Phosphate, B.P.C. | Tar Ointment, B.P.C. 1959. |
Prednisolone Tertiary Butyl Acetate. | Tartrazine, B.P.C. 1954. |
Protoveratrines A. | Testosterone Oenanthate. |
Pumilio Pine Oil, B.P.C. | Tetanus Immune Globulin (Human). |
Pyrazinamide. | Tetracycline. |
Pyridine Aldoxime Methiodide. | Thenalidine. |
| Thenalidine Tartrate. |
| Theobromine, B.P.C. |
| Theobromine and Sodium Salicylate, B.P. 1953. |
| Theophylline Ethanoate of Piperazine. |
Third Schedule—continued
Thiethylperazine. | Trimustine Hydrochloride. |
Thioridazine. | Trinitrophenol, B.P.C. 1959. |
Thiotepa. | Triprolidine Hydrochloride, B.P.C. |
Thyrotrophin. | Trolnitrate Phosphate. |
Tiger Snake Antivenene. | Vadrine. |
Titanium Dioxide, B.P.C. | Valerian Ammoniated Tincture, B.P.C. |
Tolu Tincture, B.P.C. 1959. | Vanillin. |
Tragacanth (Gum Karaya). | Vasopressin Tannate. |
Trasylol. | Velactin. |
Tretamine. | Vinblastine Sulphate. |
Triamcinolone, B.P.C. | Vincristine Sulphate. |
Triamterene. | Vinegar of Squill, B.P.C. |
Tricyclamol Chloride. | Viomycin Pantothenate. |
Tridihexethyl Chloride. | Viprynium Embonate. |
Triethanolamine, B.P.C. | Vitamin A. |
Trimeprazine Tartrate, B.P.C. | Vitamin D. |
___________________
FOURTH SCHEDULE
Regulation 12.
Additives | |
Acetone, B.P.C. B.P.C. | Caraway Oil, B.P.C. |
Alcohol (95%), B.P. | Carmine Solution, A.P.F. |
Dilute Alcohols, B.P. | Citronella Oil, B.P.C. |
Amethocaine Hydrochloride, B.P. | Xylene, B.P.C. 1949. |
________________
FIFTH SCHEDULE
Regulation 14.
Pharmaceutical Benefits the Prescribing of Which is Subject to Conditions and Restrictions
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | |
Acetylsalicylic Acid Tablets, B.P.................... |
|
|
Soluble Acetylsalicylic Acid Tablets B.P............... |
|
|
Compound Acetylsalicylic Acid Tablets, A.P.F........... |
| Any disease or condition in a pensioner |
Compound Acetylsalicylic Acid Tablets, B.P.C.......... |
|
|
Soluble Compound Acetylsalicylic Acid Tablets......... |
|
|
Acrylic Resin ................................ | Ileostomy or colostomy conditions | |
Alkavervir .................................. | Hypertensive crises | |
Aminocaproic Acid ............................ | Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Amitriptyline Hydrochloride ...................... | Any disease or condition in a patient receiving treatment in or at an approved hospital | |
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital | |
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride | |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | ||
Amphotericin B............................... | Systemic fungal infection | ||
Ampicillin Capsules, B.P........................ |
| With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Ampicillin is the only appropriate antibiotic | |
Ampicillin Injections........................... | |||
Ampicillin Tablets............................. | |||
Aneurine Hydrochloride Tablets, B.P................. | Any disease or condition in a pensioner | ||
Angiotensin Amide............................ | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||
Ascorbic Acid Tablets, B.P........................ | Any disease or condition in a pensioner | ||
Azathioprine................................. |
| Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Beclamide | |||
Bemegride Injection, B.P......................... | As an antidote to barbiturate and other hypnotic poisons | ||
Betamethasone Tablets.......................... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets | ||
Betamethasone Disodium Phosphate Injection | Intra-articular use | ||
Bethanidine Sulphate........................... | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||
Busulphan Tablets, B.P.......................... | Leukaemia | ||
|
| Any disease or condition in a pensioner | |
Calciferol Tablets, B.P........................... | With the written authority of the Director-General— | ||
Calciferol, B.P................................ | Hypoparathyroidism | ||
| Chronic hypoparathyroid tetany | ||
| Vitamin D-resistant rickets | ||
Calcium Aminosalicylate........................ | Tuberculosis | ||
Calcium Gluconogalactogluconate Effervescent Tablets.... | Hypoparathyroidism | ||
Carbamazepine............................... | Epilepsy | ||
| Trigeminal neuralgia | ||
Cephaloridine................................ | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||
Chlorambucil Tablets, B.P........................ | Malignant lymphoma and related conditions | ||
Chloramine Deodorant Tablets and Powder............ | Ileostomy or colostomy conditions | ||
Chloramphenicol Capsules, B.P..................... | Bacterial meningitis | ||
| Haemophilus influenzae infections | ||
| Intra-ocular infections | ||
| Rickettsial infections | ||
| Salmonella septicaemia | ||
| Typhoid and paratyphoid | ||
| Other serious infections sensitive only to Chloramphenicol | ||
Chloramphenicol Injections....................... |
| A disease or condition specified in this column in relation to Chloramphenicol Capsules | |
Chloramphenicol Tablets ........................ | |||
Chloramphenicol Oral Suspension | |||
Chlorotrianisene Tablets......................... | Carcinoma of the prostate | ||
Chlorpromazine Hydrochloride.................... | Any disease or condition in a pensioner | ||
| Any disease or condition in a patient receiving treatment in or at an approved hospital | ||
| With the written authority of the Director-General— | ||
| Late-stage malignancy | ||
| Radiation sickness | ||
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | ||
Chlorpromazine Hydrochloride—continued | With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital | ||
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride, or Nortriptyline Hydrochloride | ||
Chlortetracycline Capsules, B.P..................... | Brucellosis | ||
| Herpes zoster ophthalmicus | ||
| Intestinal amoebiasis | ||
| Leptospirosis | ||
| Lymphogranuloma venereum | ||
| Psittacosis | ||
| Rickettsial infections | ||
| Any bacterial infections or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins | ||
| Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur | ||
Chlortetracycline Hydrochloride Granules | A disease or condition specified in this column in relation to Chlortetracycline Capsules | ||
Choline Theophyllinate.......................... |
| Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Cloxacillin Sodium, B.P.......................... | |||
Cloxacillin Capsules, B.P......................... | |||
Compound Codeine Tablets, B.P. |
|
| |
Compound Codeine Soluble Tablets, B.P |
| ||
Codeine Phosphate with Acetylsalicylic Acid Soluble Tablets |
| ||
Codeine Phosphate with Acetylsalicylic Acid Tablets | Any disease or condition in a pensioner | ||
Codeine Phosphate with Acetylsalicylic Acid and Phenacetin Tablets |
| ||
Codeine Phosphate with Acetylsalicylic Acid, Phenacetin and Caffeine Tablets |
| ||
Cod Liver Oil Emulsion......................... | Any disease or condition in a child under the age of twelve years or in a pensioner | ||
|
| With the written authority of the Director-General— | |
Corticotrophin Injection, B.P....................... |
| A disease or condition specified in this column in relation to Cortisone Injection | |
Corticotrophin Gelatin Injection, B.P. |
| Hypsarrhythmia | |
Corticotrophin Zinc Hydroxide Injection, B.P. |
| Salaam convulsions | |
| The prevention of side effects of corticosteroid therapy | ||
Cortisone Injection, B.P.......................... | With the written authority of the Director-General— | ||
| Anaemia, acquired haemolytic | ||
| Addison’s disease | ||
| Adrenocortical hypoplasia | ||
| Adrenalectomy, total | ||
| Adrenogenital syndrome | ||
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
Cortisone Injection, B.P.—continued | With the written authority of the Director-General—continued |
| Agranulocytosis |
| Behcet’s syndrome |
| Cranial arteritis |
| Cushing’s syndrome, including hyperadrenocorticalism |
| Dermatitis, acute exfoliative |
| Dermatomyositis |
| Encephalomyelitis |
| Encephalomyelitis, acute disseminated |
| Guillain-Barré syndrome |
| Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis |
| Hansen’s disease |
| Hepatitis, progressive or continuing, proven by biopsy or biochemistry |
| Hodgkin’s disease |
| Idiopathic hypercalcaemia |
| Inflammatory conditions of the uveal tract and retina |
| Keratoplasty |
| Leucine-sensitive hypoglycaemia |
| Leukaemia |
| Lymphosarcoma and follicular lymphoma |
| Metastatic breast cancer |
| Mycosis fungoides |
| Nephrosis or nephrotic syndrome |
| Neuromyelitis optica |
| Optic neuritis following removal of tumor of the brain |
| Panhypopituitarism |
| Pemphigus |
| Periarteritis nodosa |
| Progressive transverse myelitis |
| Pseudohermaphroditism |
| Purpura, Henoch’s |
| Purpura, thrombocytopenic |
| Regional ileitis (Crohn’s disease) |
| Recticulum cell sarcoma |
| Rheumatic carditis, acute |
| Sarcoidosis |
| Scleroderma |
| Severe reactions of the skin and mucosa following X-ray therapy |
| Splenic neutropenia |
| Status asthmaticus |
| Steroid therapy prior to operation in patients under steroid therapy |
| Stevens-Johnson syndrome |
| Still’s disease in a child under the age of sixteen years |
| Sympathetic ophthalmitis |
| Systemic lupus erythematosus |
| Temporal arteritis |
| Tropical and non-tropical sprue and all forms of malabsorption associated with those diseases |
| Type II Nephritis |
| Ulcerative colitis proven by sigmoidoscopy or radiological report |
Cortisone Tablets, B.P......................... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | ||
|
| Established megalocytic anaemia | |
Cyanocobalamin Injection, B.P..................... |
| Neuroblastoma | |
|
| Subacute combined degeneration of the cord | |
Cymogran.................................. | With the written authority of the Director-General, phenylketonuria | ||
Cycloserine, B.P............................... |
| Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Cycloserine Capsules, B.P........................ | |||
Dapsone Tablets, B.P............................ | Hansen’s disease | ||
Demethylchlortetracycline Capsules, B.P. |
| A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus | |
Demethylchlortetracycline Hydrochloride Oral Paediatric Drops and Oral Suspension | |||
Deodorant Detergent Solution (Lissapol with Spearmint Oil and Cetrimide) | Ileostomy or colostomy conditions | ||
Deoxycortone Aqueous Injections |
|
| |
Deoxycortone Acetate Injection, B.P. |
| Addison’s disease | |
Deoxycortone Trimethylacetate Injection, B.P. |
| Adrenalectomy, total | |
Deoxycortone Acetate Implants, B.P. |
|
| |
Deoxycortone Acetate Tablets..................... |
|
| |
Desferrioxamine.............................. | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||
Dexamethasone Tablets, B.P....................... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets | ||
Dexamethasone Sodium Phosphate Injections | Intra-articular use | ||
Dienoestrol Cream............................. | Any disease or condition in a pensioner | ||
Dienoestrol Tablets, B.P.......................... | Carcinoma of the prostate | ||
| Mammary carcinoma | ||
| Any disease or condition in a pensioner | ||
Dihydrostreptomycin Sulphate Injection | As an alternative to Streptomycin Sulphate in the case of a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate | ||
Dihydrotachysterol............................. | Parathyroid deficiency | ||
Diiodohydroxyquinoline Vaginal Tablet |
| Trichomonal or monilial vaginitis | |
Diiodohydroxyquinoline Effervescent Gynaecological Pessary |
| ||
Diloxanide Furoate Tablets, B.P.................... | Amoebic dysentery | ||
Dimethicone................................. | Ileostomy or colostomy conditions | ||
Disodium Stilboestrol Diphosphate.................. | Carcinoma of the prostate | ||
Dithiazanine Iodide............................ | Infestations of Trichuris trichiura or Strongyloides stercoralis | ||
Ditophal.................................... | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||
Erythromycin................................ | Staphylococcal septicaemia or pneumonia | ||
| Any gram-positive bacterial infections where these cannot be treated safely and effectively by sulphonamides or penicillins | ||
Ethacrynic Acid.............................. | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||
Ethinyloestradiol Tablets, B.P...................... | Turner’s syndrome | ||
| Pre-menopausal castration syndrome | ||
| Any disease or condition in a pensioner | ||
Ethionamide................................. | Tuberculosis | ||
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | ||
Ethisterone Tablets, B.P.......................... | Turner’s syndrome | ||
Ethyloestrenol................................ | With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis | ||
Fludrocortisone Tablets, B.P....................... | Addison’s disease | ||
| Adrenocortical hypoplasia | ||
Fluorouracil Sodium............................ | Carcinoma of the colon and rectum | ||
Fluoxymesterone Tablets, B.P...................... | Castration syndrome (male and female) | ||
| Mammary carcinoma | ||
| With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis | ||
Folic Acid Injection............................ |
| Macrocytic anaemia | |
Folic Acid Tablets, B.P.......................... |
| Sprue or the sprue-like syndrome | |
Folinic Acid................................. | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||
Framycetin Sulphate Tablets...................... | Bowel sterilization preparatory to major surgery | ||
Fusidic Acid (Sodium Salt or Diethanolamine Salt) | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Fusidic Acid (Sodium Salt or Diethanolamine Salt) is the only appropriate antibiotic | ||
Galactomin.................................. | With the written authority of the Director-General, galactosaemia | ||
Goats Milk, dehydrated.......................... | With the written authority of the Director-General, cows milk allergy in children under the age of four years | ||
Griseofulvin Tablets, B.P......................... | With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination | ||
Halibut Liver Oil Capsules ....................... | Any disease or condition in a pensioner | ||
Hexachlorophane with Entsufon.................... |
| Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Hexachlorophane with Lissapol.................... | |||
Hexachlorophane in Soap Solution | |||
Hydrocortisone Injection......................... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection | ||
Hydrocortisone Acetate Injection, B.P. | Intra-articular use | ||
Hydrocortisone Sodium Succinate Injection | Acute adrenal failure due to medical or surgical crises | ||
| Stevens-Johnson syndrome | ||
Hydrocortisone Sodium Succinate Soluble Tablet | With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report | ||
| Established megalocytic anaemia | ||
Hydroxocobalamin Injection, B.P.................... | Neuroblastoma | ||
| Sub-acute combined degeneration of the cord | ||
Hydroxyprogesterone Caproate .................... | Habitual abortion | ||
| Progesterone deficiency proven by hormonal assay of lateral wall smear | ||
Idoxuridine.................................. | Infections caused by Herpes Simplex Virus | ||
Imipramine Tablets, B.P.......................... | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital | ||
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be proscribed) for supply under Part VII. of the Act | |
Imipramine Tablets, B.P.—continued | The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride | |
Isoniazid Tablets, B.P............. | Tuberculosis | |
Kanamycin Sulphate.............. | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the only appropriate antibiotic | |
Kitasamycin................... | Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Levorphanol Tartrate............. | Obstetrical use | |
| Severe intractable pain | |
Lincomycin Hydrochloride.......... | Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Liothyronine Tablets, B.P.......... | Myxoedema | |
| Myxoedema coma | |
Lipopancreatin.................. | Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Lofenalac..................... | With the written authority of the Director-General, phenylketonuria | |
Medroxyprogesterone Acetate Tablets | Endometrial carcinoma | |
Medroxyprogesterone Acetate Injections | Endometrial carcinoma | |
Habitual abortion | ||
| Progesterone deficiency proven by hormonal assay of lateral wall smear | |
Melphalan.................... | Malignant melanoma | |
| Multiple myeloma | |
Mercaptopurine Tablets, B.P........ | Allergic angiitis | |
| Leukaemia | |
| Lupus erythematosus | |
| Periarteritis | |
Mestanolone................... | Mammary carcinoma | |
| With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis | |
Methacycline................... | A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus | |
Methandienone Tablets, B.P......... |
| With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis |
Methenolone Acetate.............. | ||
Methicillin Sodium............... |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
Methicillin Injection, B.P........... | ||
Methotrexate Tablets............. | Leukaemia and neoplastic disease | |
Methotrexate Injections............ | Any disease or condition in a patient receiving treatment in or at an approved hospital. | |
Metyrapone.................... | Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Minafen...................... | With the written authority of the Director-General, phenylketonuria | |
Morphine Sulphate, B.P. with Tacrine Tablets | Severe intractable pain | |
Mustine Hydrochloride Injection...... | Malignant lymphoma and related conditions | |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | |||||
Nalidixic Acid.................. | With the written authority of the Director-General’ urinary tract infections where positive bacteriological evidence confirms that Nalidixic Acid is the only appropriate drug | |||||
Nandrolone Phenylpropionate Injection, B.P. |
| With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis | ||||
Nandrolone Decanoate............ | ||||||
Natamycin.................... | Monilial infections | |||||
Neomycin Tablets, B.P............ | Bowel sterilization preparatory to major surgery | |||||
Nicotinic Acid Tablets, B.P......... | Any disease or condition in a pensioner | |||||
Nitrofurantoin Tablets, B.P......... |
| Urinary tract infections | ||||
Nitrofurantoin Oral Suspension....... | ||||||
Nitromin..................... | Malignant lymphoma and related conditions | |||||
Nortriptyline Hydrochloride......... | Any disease or condition in a patient receiving treatment in or at an approved hospital. | |||||
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital | |||||
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride | |||||
Nystatin Vaginal Tablets........... |
| Proven monilia infections | ||||
Nystatin Tablets, B.P............. | ||||||
| ||||||
Orciprenaline Sulphate Injection...... | ||||||
Orciprenaline Sulphate Solution for Inhalation .. .. |
| Any disease or condition in a patient receiving treatment in or at an approved hospital | ||||
Oxycodone Pectinate............. | Late-stage malignancy | |||||
Oxymesterone.................. | With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis | |||||
Oxytetracycline Hydrochloride Capsules | ||||||
Oxytetracycline Tablets, B.P........ |
| A disease or condition specified in this column in reflation to chlortetracycline Capsules except herpes zoster ophthalmicus | ||||
Oxytetracycline Injections | ||||||
Calcium di-Oxytetracycline Oral Suspension | ||||||
Calcium di-Oxytetracycline Paediatric Drops | ||||||
|
| Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis | ||||
Oxytetracycline Hydrochloride with a buffering agent and Nystatin | A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus | |||||
Pancreatin, B.P................. |
| Fibrocystic disease | ||||
Pancreatin Enzyme U.S.N.F. XI...... | Pancreatico-duodenectomy | |||||
| Pancreatic steatorrheoa | |||||
Para-Aminosalicylic Acid.......... | Tuberculosis | |||||
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | |||||
Paracetamol Suspension........... |
| Any disease or condition in a pensioner | ||||
Paracetamol Tablets, B.P........... | ||||||
Paramethasone Acetate............ | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection | |||||
Paraffin Liquid Emulsion........... |
| Any disease or condition in a pensioner | ||||
Paraffin Liquid Emulsion with Phenolphthalein .. .. | ||||||
Pargyline Hydrochloride........... | Any disease or condition in a patient receiving treatment in or at an approved hospital | |||||
Penicillamine.................. | With the written authority of the Director-General, Wilson’s disease (hepatolenticular degeneration) | |||||
| Cystinuria with multiple renal calculi | |||||
Pethidine Hydrochloride with Levallorphan Tartrate | Obstetrical use | |||||
Benzylpenicillin with Streptomycin Sulphate |
| Endocarditis due to Streptococcus faecalis or Streptococcus viridans | ||||
Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate | ||||||
Phenacetin with Codeine Phosphate and Pentobarbitone Sodium | Any disease or condition in a pensioner | |||||
Phytomenadione Injection, B.P....... | Antidote to anticoagulants | |||||
Pituitary, Posterior Lobe, Insufflation | Diabetes insipidus | |||||
Polymyxin B. Sulphate Injection...... | Any disease or condition in a patient receiving treatment in or at an approved hospital | |||||
Prednisolone Sodium Phosphate Retention Enema | With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report | |||||
Prednisolone Tablets, B.P.......... | With the written authority of the Director-General— | |||||
| Nodular non-suppurative panniculitis (Christian-Weber disease) | |||||
| A disease or condition specified in this column in relation to Cortisone Injection except total adrenalectomy, Addison’s disease or adrenocortical hypoplasia | |||||
Prednisolone Acetate Injection....... |
| Intra-articular use | ||||
Prednisolone Methyl Acetate Injections. | ||||||
Prednisolone Tertiary Butyl Acetate Injections | ||||||
Prednisolone Trimethylacetate Injections | ||||||
Methylprednisolone Tablets, B.P...... |
| With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets | ||||
Methylprednisolone Capsules........ | ||||||
| ||||||
Prednisolone Sodium Hemisuccinate | With the written authority of the Director-General, medical or surgical crises | |||||
Prednisone Tablets, B.P............ | With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets | |||||
|
| Habitual abortion | ||||
Progesterone................... | Progesterone deficiency proven by hormonal assay of lateral wall smear | |||||
Protoveratrine A................ | Hypertensive crises | |||||
Pyrazinamide.................. | Any disease or condition in a patient receiving treatment in or at an approved hospital | |||||
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | ||||
Pyridostigmine Injection, B.P-------- |
| Myasthenia gravis | |||
Pyridostigmine Tablets, B.P......... | |||||
Pyridoxine Hydrochloride Tablets | Peripheral neuritis due to isoniazid therapy | ||||
| Radiation sickness | ||||
Riboflavine Tablets.............. |
| Any disease or condition in a pensioner | |||
Senna Fruit Extract (Standardised) | |||||
Sobee........................ | With the written authority of the Director-General— | ||||
| Galactosaemia | ||||
| Lactose intolerance | ||||
| Milk allergy in children under the age of four years | ||||
Sodium Aminosalicylate Tablets. B.P. |
| Tuberculosis | |||
Sodium Aminosalicylate Injection | |||||
Sodium Aminosalicylate Cachets | |||||
Sodium Aminosalicylate Granules | |||||
Sodium Folate.................. | Macrocytic anaemia | ||||
| Sprue or the sprue-like syndrome | ||||
Spiramycin.................... | A disease or condition specified in this column in relation to Erythromycin | ||||
Spironolactone Tablets, B.P......... | With the written authority of the Director-General, to supplement other diuretics when these have proved inadequate. | ||||
Stanolone..................... | Mammary carcinoma | ||||
| With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis | ||||
Stanozolol.................... | With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis | ||||
Stilboestrol Injection.............. |
| Carcinoma of the prostate | |||
Stilboestrol Tablets, B.P........... | Mammary carcinoma | ||||
| Any disease or condition in a pensioner | ||||
Streptomycin Sulphate Injections..... | Bacillary dysentery that is resistant to the Sulphonamides | ||||
| Brucellosis | ||||
| Chancroid | ||||
| Endocarditis due to Streptococcus faecalis or Streptococcus viridans | ||||
| Friedlander bacillus infections | ||||
| Haemophilus influenzae infections | ||||
| Plague | ||||
| Pseudomonas pyocyanea infections | ||||
| Rat-bite fever (Streptobacillus moniliformis) | ||||
| Salmonella infections | ||||
| Surgical conditions of the bowel (pre-operative and post-operative) | ||||
| Surgical conditions of the thoracic organs | ||||
| Tuberculosis | ||||
| Tularaemia | ||||
| Urinary tract infections that are resistant to the Sulphonamides | ||||
Sulphasalazine.................. | Ulcerative colitis | ||||
Sulphomyxin Sodium............. | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||||
Sultiame...................... | For use where other anticonvulsants have failed | ||||
Surgical Cement................ |
| Ileostomy or colostomy conditions | |||
Surgical Cement Solvent........... | |||||
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | |||||
Sustanon.......................... |
| |||||
Testosterone Implants, B.P.............. |
|
| ||||
Testosterone Oenanthate............... | Castration syndrome (male and female) | |||||
Testosterone Propionate Injection, B.P...... | Klinefelter Reifenstein Albright syndrome | |||||
Methyltestosterone Tablets, B.P.......... | Mammary carcinoma | |||||
Methyltestosterone, B.P................ |
| |||||
Tetanus Immune Globulin (Human) | With the written authority of the Director-General, where patients are known to be sensitive to horse serum and cattle scrum | |||||
Tetracycline Capsules, B.P.............. |
| A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus | ||||
Tetracycline Tablets, B.P............... | ||||||
Tetracycline Injections................ | ||||||
Tetracycline Hydrochloride, with a buffering agent—Capsules and Injection | ||||||
Rolitetracycline..................... | ||||||
Tetracycline Granules................. | ||||||
Tetracycline Paediatric Drops............ | ||||||
Tetracycline Oral Suspension............ | ||||||
Tetracycline with a buffering agent—Paediatric Drops | ||||||
Tetracycline with a buffering agent—Oral Suspension | ||||||
Tetracycline with a buffering agent and Amphotericin B |
| Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis | ||||
| A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus | |||||
Tetracycline with a buffering agent and Nystatin | ||||||
Thiambutosine Tablets, B.P............. | Hansen’s disease | |||||
|
| Any disease or condition in a pensioner | ||||
| Any disease or condition in a patient receiving treatment in or at an approved hospital | |||||
| With the written authority of the Director-General— | |||||
| Late-stage malignancy | |||||
| Radiation sickness | |||||
Thioridazine Tablets, B.P............... | With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital | |||||
Thioridazine....................... | ||||||
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride | |||||
Thyrotrophin....................... | Any disease in or condition in a patient receiving treatment in or at an approved hospital | |||||
Tragacanth (Gum Karaya).............. | Ileostomy or colostomy conditions | |||||
Trasylol.......................... | Any disease or condition in a patient receiving treatment in or at an approved hospital | |||||
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | ||
Tretamine......................... | Malignant lymphoma and related conditions | ||
Triamcinolone...................... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets | ||
Trifluoperazine Tablets, B.P............. | Any disease or condition in a pensioner | ||
| Any disease or condition in a patient receiving treatment in or at an approved hospital | ||
| With the written authority of the Director-General— | ||
| Late-stage malignancy | ||
| Radiation sickness | ||
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital | ||
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride Imipramine Hydrochloride or Nortriptyline Hydrochloride | ||
Trimetaphan Injection, B.P.............. | Hypotensive for anaesthesia | ||
Vadrine.......................... | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||
Vasopressin Nasal Spray............... | Diabetes insipidus | ||
Velactin.......................... | With the written authority of the Director-General— | ||
| Galactosaemia | ||
| Lactose intolerance | ||
| Milk allergy in children under the age of four years | ||
Vinblastine Sulphate.................. | Hodgkin’s disease | ||
Vincristine Sulphate.................. | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||
Viomycin Sulphate................... |
| ||
Viomycin Sulphate Injection, B.P. |
| Tuberculosis | |
Viomycin Sulphate with Viomycin Pantothenate |
| ||
Vitamin A with Aneurine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D |
| Any disease or condition in a pensioner | |
_______________________
By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra